CRISPR Therapeutics Wins ISPE Facility of the Year Award for Innovation
CRISPR Therapeutics has been awarded a 2022 ISPE Facility of the Year Award in the Innovation category for its new cGMP manufacturing facility in Framingham. This 50,000 SF facility has been recognized by ISPE for its unique compact design capable of producing different products at different stages of development, its integration of digital tools into the design, and its innovative approach to building flexibility into the facility. Congratulations to the CRISPR team!
Read more about CRISPR’s Framingham award-winning facility and the innovative work the are doing on the ISPE website.
- Owner – CRISPR Therapeutics
- Project Manager – Leggat McCall Properties
- Architect – TRIA Design
- General Contractor/CM – Commodore Builders LLC